Non-invasive delivery of nebulized surfactant has been a neonatology long-pursued goal. Nevertheless, the clinical efficacy of nebulized surfactant remains inconclusive, in part, due to the great technical challenges of depositing nebulized drugs in the lungs of preterm infants. The aim of this study was to investigate the feasibility of delivering nebulized surfactant (poractant alfa) in vitro and in vivo with an adapted, neonate-tailored aerosol delivery strategy.
From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy / Bianco, F; Ricci, F; Catozzi, C; Murgia, X; Schlun, M; Bucholski, A; Hetzer, U; Bonelli, S; Lombardini, M; Pasini, E; Nutini, M; Pertile, M; Minocchieri, S; Simonato, M; Rosa, B; Pieraccini, G; Moneti, G; Lorenzini, L; Catinella, S; Villetti, G; Civelli, M; Pioselli, B; Cogo, P; Carnielli, V; Dani, C; Salomone, F. - In: RESPIRATORY RESEARCH. - ISSN 1465-993X. - STAMPA. - 20:1(2019), p. 134. [10.1186/s12931-019-1096-9]
From bench to bedside: in vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy
Carnielli, V;
2019-01-01
Abstract
Non-invasive delivery of nebulized surfactant has been a neonatology long-pursued goal. Nevertheless, the clinical efficacy of nebulized surfactant remains inconclusive, in part, due to the great technical challenges of depositing nebulized drugs in the lungs of preterm infants. The aim of this study was to investigate the feasibility of delivering nebulized surfactant (poractant alfa) in vitro and in vivo with an adapted, neonate-tailored aerosol delivery strategy.| File | Dimensione | Formato | |
|---|---|---|---|
|
unpaywall-bitstream--1001645661.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza d'uso:
Creative commons
Dimensione
1.16 MB
Formato
Adobe PDF
|
1.16 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
